Key points from article :
First Longevity Ltd has been formed to capitalise on the growing Longevity opportunity.
This news platform delivers daily news and insights to investors, start-ups, academics and consumers.
Jim Mellon and Bruce Barclay join the First Longevity funding round.
Bruce Barclay is an investor, entrepreneur and philanthropist based in Switzerland.
“Significant technological advances in recent years are now allowing a deep understanding of why people age and how to “make aging optional” - Barclay, a member of the Board of Trustees at the Buck Institute.
Jim is chairman of Juvenescence, entrepreneur, philanthropist and investor with interests in several industries.
“Editorial skills with investor insights will bring together longevity investors and entrepreneurs” - Mellon, Juvenescence chairman.
Crowd Longevity present pre-screened Longevity tech opportunities to our growing investor community.
